QRS Duration Versus Morphology and Survival After Cardiac Resynchronization Therapy
Open Access
- 1 December 2016
- journal article
- research article
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 4 (1) , 23-30
Abstract
The prognostic implications of QRS duration and morphology in heart failure patients treated with cardiac resynchronization therapy (CRT) remains debated. The present evaluation investigated the association between QRS duration (P = 0.010], whereas there was no statistically significant association between QRS duration ≥150 ms and survival (HR 0.889; 95% CI 0.726–1.088; P = 0.252). In this large population of heart failure patients treated with CRT, QRS morphology was independently associated with long-term survival. The association between QRS duration and long-term survival was not statistically significant.Keywords
This publication has 26 references indexed in Scilit:
- Assessment of Long-Term Effects of Irbesartan on Heart Failure With Preserved Ejection Fraction as Measured by the Minnesota Living With Heart Failure Questionnaire in the Irbesartan in Heart Failure With Preserved Systolic Function (I-PRESERVE) TrialCirculation: Heart Failure, 2012
- Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT-CRT)Circulation, 2011
- Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart FailureNew England Journal of Medicine, 2010
- Value of Tissue Doppler Echocardiography in Predicting Response to Cardiac Resynchronization Therapy in Patients With Heart FailureThe American Journal of Cardiology, 2010
- Analysis of Ventricular Activation Using Surface Electrocardiography to Predict Left Ventricular Reverse Volumetric Remodeling During Cardiac Resynchronization TherapyCirculation, 2010
- AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the ElectrocardiogramJACC, 2009
- Randomized Trial of Cardiac Resynchronization in Mildly Symptomatic Heart Failure Patients and in Asymptomatic Patients With Left Ventricular Dysfunction and Previous Heart Failure SymptomsJACC, 2008
- Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm AssociationEuropean Heart Journal, 2007
- The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart FailureNew England Journal of Medicine, 2005
- Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart FailureNew England Journal of Medicine, 2004